Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interferon Alpha In Combination With Thalidomide In The Treatment Of Metastatic Renal Cell Carcinoma A Randomized Phase II Study

NCT00027664 is registered in ClinicalTrials.gov with Cancer Research UK as lead sponsor.

NCT NCT00027664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00027664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interferon Alpha In Combination With Thalidomide In The Treatment Of Metastatic Renal Cell Carcinoma A Randomized Phase II Study
Lead sponsor
Cancer Research UK
Phase
Phase 2
Overall status
Unknown status
Start date
February 28, 2001
Completion date
Not reported
Enrollment
90 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer